We found that treatment with Liq downregulated the expression of many genes involved in NF-κB pathway and negatively correlated with NF-κB signaling pathway and inflammation, further supporting the notion that Liq-mediated tumor suppression involves the attenuation of inflammatory pathways. This evidence concerns the gene NFKB1 and neoplasm.